NEW YORK – Beckman Coulter Diagnostics said Tuesday that it has acquired StoCastic, a startup informatics company that develops artificial intelligence-based clinical decision support for hospital emergency departments. Financial terms were not disclosed.
Brea, California-based Beckman Coulter, part of Danaher, will make Towson, Maryland-based StoCastic's TriageGo software a "cornerstone" of its own clinical decision support offerings, providing automated triage services by connecting hospitals' electronic health records with ED workflow systems.
"Bringing in StoCastic innovations and talent to Beckman Coulter is an exciting step for our plans to develop a full portfolio of CDS solutions," Beckman Coulter Diagnostics President Julie Sawyer Montgomery said in a statement.
"With the StoCastic acquisition, we combine Beckman Coulter Diagnostics biomarkers with TriageGo's evidence-based CDS to generate advanced decision support insights," added Kelly Sager, VP and general manager of CDS Solutions at Beckman Coulter Diagnostics. "This will enable clinicians to make informed decisions sooner and further improve patient outcomes."